Baxa Corporation and Health Robotics Announce Strategic Alliance to Automate IV Admixture Preparation
Baxa Corporation and Health Robotics announce a strategic alliance to use the Baxa Two-Fer™ Needles with Health Robotics' CytoCare™ Robot in order to safely and accurately automate the preparation of patient-specific chemotherapy IV admixtures. This alliance combines state-of-the-art technologies to achieve the accuracy and sterility that providers require for automating patient-specific IV admixture preparations. The resulting technology is the only totally automated system for handling hazardous IV admixtures available in the market.
Englewood, Colo. (PRWEB) June 18, 2007 -- Baxa Corporation and Health Robotics announce a strategic alliance to automate the preparation of patient-specific chemotherapy drug admixtures. Under the agreement, Health Robotics will optimize its technology for the exclusive use of the Baxa Two-Fer™ Needles in the automated vial and final containers' access steps for its CytoCare™ Robot. Baxa Two-Fer Needles provide a unique design that can be used for vented or non-vented vial access. Their Huber tip prevents vial coring, making it ideal for safe access; whether in an automated device or for manual preparations.
With its CytoCare™ Robot, Health Robotics has the first totally automated system for safe preparation of patient-specific hazardous IV doses. "CytoCare constitutes a breakthrough advance for patient and clinician's safety," says Werner Rainer, General Manager, Health Robotics. "This alliance combines state-of-the-art technologies to achieve the accuracy and sterility that providers require for automating patient-specific IV admixture preparations," he adds. The resulting technology is the only totally automated system for handling hazardous IV admixtures available in the market.
The strategic alliance fits with Baxa Corporation's mission of providing world-class technology for pharmacy operations. Greg Baldwin, Chairman and CEO of Baxa Corporation notes, "Baxa is pleased to have been selected by Health Robotics to utilize exclusively the Two-Fer Needle with the CytoCare Robot. "It is wonderful to see that the same features that made Two-Fer Needles the vial access product of choice with pharmacy staff worldwide are preferred for this new generation of pharmacy robots being pioneered by Health Robotics."
Both companies will be exhibiting at the 2007 American Society of Health-System Pharmacists (ASHP) Summer Meeting, June 24-27, 2007 in San Francisco, California. Participants can learn more about the CytoCare Robot (Health Robotics booth 123) and Two-Fer Needles (Baxa Corporation booth 515) during the exhibit hours of the industry meeting.
Baxa Corporation provides systems and products that streamline pharmacy operations for oral liquid delivery, sterile IV preparation and mixing multi-source parenteral solutions. The company's products provide solutions for enhancing patient safety, improving drug preparation procedures and reducing the opportunity for medication errors.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Key products include Rapid-Fill™ Automated Syringe Fillers, Exacta-Med® Oral Dispensers, MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, and Exacta-Mix™ and MicroMacro™ Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at http://www.baxa.com
About Health Robotics GmbH
Health Robotics is the leading global supplier in the automation of life-critical intravenous patient-specific medication preparation, especially chemotherapy. Its mission is to provide healthcare facilities with automated solutions that ease pharmacies' growing pressures by improving patient safety, reducing life-threatening medication errors and contamination risks, working more efficiently, increasing throughput, and containing spiraling chemotherapy expenses. Further information is available at http://www.health-robotics.com
Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation http://www.baxa.com - 800.567.2292 ext. 2157 or 303.617.2157
Maggie Chamberlin Holben, APR
Absolutely Public Relations http://www.absolutelypr.com - 303.984.9801 or 303.669.3558
Werner Rainer, General Manager
Health Robotics GmbH http://www.health-robotics.com - +39 0471200372
Altmanstrasse 9/A, Bozen, Italy 39100
###
|
